Facebook
X
LinkedIn
ForwardAtrius Health Central OB/GYN CME Presents: OB/GYN June 2025 CME/CNE, 6/18/2025
Claiming Credit for Session
Thank you for attending Atrius Health's OB/GYN meeting on June 18,2025. Once logged in, please click on "Take Course" on the right-hand side and your enrollment will be recorded. You will be prompted to take an evaluation to claim your credit on the following page.
Educational Needs Addressed
In this meeting, Atrius Health discussed the current challenges, guideline advancements and treatment in OB/GYN practice as identified by their internal specialists and CME planning committee. The latest practice data and findings were discussed with the goal of further improving internal practice and treatments.
Target Audience
Atrius Health OB/GYN Clinicians
Learning Objectives
At the completion of this activity, participants will be better able to:
- Review OBGYN-related practice and personnel updates, CME/CEU resources for credits
- Leadership update on goals for the specialty
- Provide updates to ACOG-endorses clinical guidelines
- Explore evidence-based approaches and techniques to provide safe and quality educational experiences to medical students in the clinical setting
- Identify evidence-based risk factors for adverse neonatal outcomes and consider applying a prediction model to help guidance clinical decision making
- Review & discuss evaluation & management guidelines for patients who present with pelvic pain in the outpatient setting
- Review best practice approaches to the use of continuous glucose monitors in pregnant and postpartum patients, as well as the risks and benefits of such devices
Faculty Presenters and Disclosures
Christopher Morrison, MD
Course Director
Obstetrics and Gynecology
Atrius Health
Dr. Barreveld is an advisor for BioMedict, Lin Health, Noema Pharma and is a consultant and speaker for Vertex Pharmaceuticals.
Dr. Clapp is a consultant and a private equity holder for Delfina Care.
Drs. Diaz, Erlich, Hale, Morrison, and Vadnais have no relevant financial relationships to disclose. Ms. Molly Holmes, RN has no relevant financial relationships to disclose.
Drs. Bareveld and Clapp will discuss the unlabeled/investigational uses of oral medications such as gabapentin or SNRIs. In addition, the off-label use of topical compounds for all types of pain will be discussed.
Planning Committee
Drs. Li, Morrison, Platek, Richardson, and Ms. Caitlyn Mayhew have no relevant financial relationships to disclose.
Meghan Bride, NP planning committee member, is a trainer for Organon/Merck.
Accreditor Disclosures
The following planning committee members from Boston University Chobanian & Avedisian School of Medicine’s Office of Continuing Medical Education have no relevant financial relationships: Michael Burk, BS, Operations Manager; Daniel Alford, MD, Assistant Dean.
Accreditor Disclosure Policy
Boston University Chobanian & Avedisian School of Medicine asks all individuals involved in the development and presentation of Accredited Continuing Education activities to disclose all financial relationships with ineligible companies. This information is disclosed to all activity participants prior to the start of the educational activity. Boston University Chobanian & Avedisian School of Medicine has procedures to mitigate all relevant financial relationships with ineligible companies. In addition, faculty members are asked to disclose when any unapproved use of pharmaceuticals and devices is being discussed.
In accordance with the Standards for Integrity and Independence in Accredited Continuing Education, all relevant financial relationships with ineligible companies that faculty, planners, authors and anyone who may be in control of content have been mitigated.
Disclaimer
THESE MATERIALS AND ALL OTHER MATERIALS PROVIDED IN CONJUNCTION WITH CONTINUING EDUCATION ACTIVITIES ARE INTENDED SOLELY FOR PURPOSES OF SUPPLEMENTING CONTINUING EDUCATION PROGRAMS FOR QUALIFIED HEALTH CARE PROFESSIONALS. ANYONE USING THE MATERIALS ASSUMES FULL RESPONSIBILITY AND ALL RISK FOR THEIR APPROPRIATE USE. TRUSTEES OF BOSTON UNIVERSITY MAKES NO WARRANTIES OR REPRESENTATIONS WHATSOEVER REGARDING THE ACCURACY, COMPLETENESS, CURRENTNESS, NONINFRINGEMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE OF THE MATERIALS. IN NO EVENT WILL TRUSTEES OF BOSTON UNIVERSITY BE LIABLE TO ANYONE FOR ANY DECISION MADE OR ACTION TAKEN IN RELIANCE ON THE MATERIALS. IN NO EVENT SHOULD THE INFORMATION IN THE MATERIALS BE USED AS A SUBSTITUTE FOR PROFESSIONAL CARE. IN NO EVENT SHOULD INFORMATION IN THE MATERIALS REGARDING LAWS, REGULATIONS, OR LEGAL LIABILITY BE CONSIDERED LEGAL ADVICE OR USED AS A SUBSTITUTE FOR CONSULTING WITH AN ATTORNEY.
In support of improving patient care, this activity has been planned and implemented by Boston University Chobanian & Avedisian School of Medicine and Atrius Health. Boston University Chobanian & Avedisian School of Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician AMA PRA Category 1 Credit™
Boston University Chobanian & Avedisian School of Medicine designates this live activity for a maximum of 3.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Risk Management
This program includes 3.5 hours which meet the criteria of the Massachusetts Board of Registration in Medicine for risk management study.
Nursing Accreditation
Contact Hours: 3.5, of which 1.0 are eligible for pharmacology credit.
Interprofessional Continuing Education Credit
This activity was planned by and for the healthcare team, and learners will receive 3.5 Interprofessional Continuing Education (IPCE) credits for learning and change.
Available Credit
- 3.50 AMA PRA Category 1 Credit™
Boston University Chobanian & Avedisian School of Medicine designates this Live activity for a maximum of 3.50 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 3.50 MA Risk Management
- 3.50 ANCC
- 1.00 ANCC Pharmacology
- 3.50 Participation